Table 4. Prevalence (%) of HBsAg and HBeAg antigenemia, in 2000 and 2010.
| Previous estimates for 2000a | Current estimates for 2000b | Estimates for 2010b | ||||
| Region | Prevalence of HBsAg antigenemia | Proportion of HBsAg+ who are HBeAg+ | Prevalence of HBsAg antigenemia | Proportion of HBsAg+ who are HBeAg+ | Prevalence of HBsAg antigenemia | Proportion of HBsAg+ who are HBeAg+ |
| AFR D | 11.51 | 20 | 8.71 | 38.2 | 7.50 | 36.3 |
| AFR E | 11.84 | 20 | 6.93 | 39.9 | 6.46 | 34.7 |
| AMR B | 1.61 | 20 | 2.80 | 36.9 | 1.09 | 31.6 |
| AMR D | 2.01 | 20 | 4.48 | 37.8 | 3.71 | 32.6 |
| EMR D | 4.32 | 20 | 3.93 | 34.3 | 3.49 | 29.0 |
| EUR B | 5.51 | 20 | 4.06 | 33.1 | 3.17 | 28.6 |
| EUR C | 3.84 | 20 | 3.93 | 29.6 | 3.51 | 25.7 |
| SEAR B | 9.00 | 50 | 4.80 | 41.4 | 3.83 | 34.9 |
| SEAR D | 3.59 | 20 | 3.20 | 33.4 | 3.05 | 27.3 |
| WPR B | 11.83 | 50 | 7.01 | 38.3 | 7.28 | 32.1 |
a
Used in Hauri et al., and Hutin et al.1,3
b
Derived from data available in Ott et al.43,44